PriceTargets.com logo

ETR:SBS - Stratec Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: €128.00
  • Forecasted Upside: 17.43 %
  • Number of Analysts: 4
  • Breakdown:
  • 1 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
€109.00 As of 04/21/2021 01:00 AM ET
▼ -0.6 (-0.55%)
1 month | 3 months | 12 months
Get New Stratec Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SBS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SBS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
€128.00
▲ +17.43% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Stratec in the last 3 months. The average price target is €128.00, with a high forecast of €151.00 and a low forecast of €102.00. The average price target represents a 17.43% upside from the last price of €109.00.
Hold
The current consensus among 4 polled investment analysts is to hold stock in Stratec. This rating has held steady since August 2019, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
10/30/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/28/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/27/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
7/26/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
10/24/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
1/22/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
3/23/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings
Ratings as of
4/22/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 1 sell ratings

DateBrokerageActionRatingPrice TargetDetails
4/7/2021Deutsche Bank AktiengesellschaftSet Price TargetBuy€151.00
i
4/6/2021Warburg ResearchSet Price TargetSell€102.00
i
4/6/2021Berenberg BankSet Price TargetNeutral€130.00
i
4/1/2021Deutsche Bank AktiengesellschaftSet Price TargetBuy€151.00
i
3/31/2021Berenberg BankSet Price TargetNeutral€130.00
i
3/31/2021Warburg ResearchSet Price TargetSell€102.00
i
2/22/2021Deutsche Bank AktiengesellschaftSet Price TargetBuy€151.00
i
2/19/2021Berenberg BankSet Price TargetNeutral€130.00
i
12/9/2020Kepler Capital MarketsSet Price TargetBuy€129.00
i
11/11/2020Berenberg BankSet Price TargetBuy€124.00
i
11/5/2020Warburg ResearchSet Price TargetSell€98.00
i
11/2/2020Berenberg BankSet Price TargetBuy€135.00
i
9/24/2020Berenberg BankSet Price TargetBuy€135.00
i
8/28/2020Warburg ResearchSet Price TargetSell€98.00
i
8/24/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€136.00
i
8/19/2020Berenberg BankSet Price TargetBuy€135.00
i
8/13/2020Berenberg BankSet Price TargetBuy€115.00
i
8/13/2020Warburg ResearchSet Price TargetNeutral€69.00
i
8/13/2020Kepler Capital MarketsSet Price TargetBuy€95.00
i
8/5/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€111.00
i
7/24/2020Berenberg BankSet Price TargetBuy€115.00
i
5/21/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€97.00
i
5/15/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€97.00
i
5/15/2020Warburg ResearchSet Price TargetNeutral€69.00
i
5/6/2020Deutsche Bank AktiengesellschaftSet Price TargetBuy€97.00
i
5/5/2020Kepler Capital MarketsSet Price TargetBuy€95.00
i
5/5/2020Warburg ResearchSet Price TargetNeutral€69.00
i
4/6/2020Warburg ResearchSet Price TargetNeutral€69.00
i
3/26/2020Berenberg BankSet Price TargetBuy€80.00
i
11/8/2019Deutsche Bank AktiengesellschaftSet Price TargetBuy€74.00
i
10/21/2019Warburg ResearchSet Price TargetNeutral€66.00
i
8/22/2019Berenberg BankSet Price TargetBuy€71.00
i
10/22/2018Berenberg BankSet Price TargetNeutral€55.00
i
8/22/2018Kepler Capital MarketsSet Price TargetBuy€75.00
i
6/4/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy€81.00
i
5/14/2018Berenberg BankSet Price TargetNeutral€68.40
i
5/9/2018Deutsche Bank AktiengesellschaftSet Price TargetNeutral€70.00
i
4/19/2018Warburg ResearchSet Price TargetNeutral€62.00
i
4/11/2018Deutsche Bank AktiengesellschaftSet Price TargetNeutral€71.00
i
1/22/2018Deutsche Bank AktiengesellschaftSet Price TargetNeutral€62.00
i
12/7/2017Berenberg BankSet Price TargetNeutral€59.00
i
10/30/2017Berenberg BankSet Price TargetNeutral€59.00
i
10/27/2017Kepler Capital MarketsSet Price TargetBuy€70.00
i
10/26/2017Warburg ResearchSet Price TargetBuy€62.00
i
10/24/2017Deutsche Bank AktiengesellschaftSet Price TargetNeutral€56.00
i
10/23/2017Oddo BhfSet Price TargetNeutral€58.00
i
10/23/2017Berenberg BankSet Price TargetNeutral€57.00
i
7/27/2017Deutsche Bank AktiengesellschaftSet Price TargetNeutral€55.00
i
7/26/2017Kepler Capital MarketsSet Price TargetBuy€66.00
i
7/25/2017Warburg ResearchSet Price TargetBuy€62.00
i
7/25/2017Berenberg BankSet Price TargetNeutral€59.00
i
7/24/2017Oddo SecuritiesSet Price TargetNeutral€58.00
i
(Data available from 4/22/2016 forward)
Stratec logo
STRATEC SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates in three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Smart Consumables segment develops and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technology. STRATEC SE also develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to STRATEC SE in December 2018. STRATEC SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
Read More

Today's Range

Now: €109.00
€107.40
€109.60

50 Day Range

MA: €113.96
€107.00
€118.60

52 Week Range

Now: €109.00
€74.50
€145.00

Volume

4,439 shs

Average Volume

6,253 shs

Market Capitalization

$1.32 billion

P/E Ratio

52.61

Dividend Yield

0.82%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Stratec?

The following Wall Street analysts have issued reports on Stratec in the last twelve months: Berenberg Bank, Deutsche Bank Aktiengesellschaft, Kepler Capital Markets, and Warburg Research.
View the latest analyst ratings for SBS.

What is the current price target for Stratec?

4 Wall Street analysts have set twelve-month price targets for Stratec in the last year. Their average twelve-month price target is €128.00, suggesting a possible upside of 17.4%. Deutsche Bank Aktiengesellschaft has the highest price target set, predicting SBS will reach €151.00 in the next twelve months. Warburg Research has the lowest price target set, forecasting a price of €102.00 for Stratec in the next year.
View the latest price targets for SBS.

What is the current consensus analyst rating for Stratec?

Stratec currently has 1 sell rating, 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in SBS, but not buy more shares or sell existing shares.
View the latest ratings for SBS.

What other companies compete with Stratec?

Other companies that are similar to Stratec include Convatec Group, Butterfly Network, 908 Devices, Drägerwerk AG & Co. KGaA, Avacta Group, Viemed Healthcare, Asensus Surgical, Itamar Medical, Viemed Healthcare, Creo Medical, Talis Biomedical, Titan Medical, Medica Group, Xtant Medical and Hamilton Thorne.

How do I contact Stratec's investor relations team?

Stratec's physical mailing address is Gewerbestr. 37, BIRKENFELD, 75217, Germany. The company's listed phone number is +49-7082-79160. The official website for Stratec is www.stratec.com.